Log in
OTCMKTS:OCPNY

OLYMPUS CORP/S Stock Forecast, Price & News

$19.80
-0.64 (-3.13 %)
(As of 09/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$19.71
Now: $19.80▼
$19.89
50-Day Range
$18.18
MA: $19.75▼
$20.62
52-Week Range
$11.09
Now: $19.80▼
$20.74
Volume182,855 shs
Average Volume23,176 shs
Market Capitalization$27.14 billion
P/E Ratio70.71
Dividend Yield0.34%
Beta0.7
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices. The company also provides upright, polarizing, inverted, laser scanning confocal, stereo, and marco fluorescence microscopes; box-type fluorescence imaging devices, microscope digital cameras, life science imaging software, bio-imaging systems, and virtual slide systems; metallurgical, semiconductor and flat-panel display inspection, laser scanning, and measuring microscopes; microscopic 3D measurement instruments, and industrial microscope ancillary equipment; and industrial videoscopes and fiberscopes, industrial rigidscopes and ancillary equipment, ultrasonic flaw detectors, eddy current and phased array flaw detectors, and X-ray fluorescence and X-ray diffraction analyzers. In addition, it offers interchangeable lens cameras, compact digital cameras, digital camera accessories, lens barrels units, optical components, digital audio recorders, binoculars, and related software applications; and biomedical materials system. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
Read More
OLYMPUS CORP/S logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.19 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Structural clay products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:OCPNY
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.olympus-global.com
Phone813-3340-2111

Debt

Debt-to-Equity Ratio0.78
Current Ratio1.75
Quick Ratio1.22

Price-To-Earnings

Trailing P/E Ratio70.71
Forward P/E Ratio63.87
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.32 billion
Price / Sales3.71
Cash Flow$0.79 per share
Price / Cash Flow24.98
Book Value$2.51 per share
Price / Book7.89

Profitability

EPS (Most Recent Fiscal Year)$0.36
Net Income$475.36 million
Net Margins5.34%
Return on Equity10.82%
Return on Assets3.98%

Miscellaneous

Employees35,174
Outstanding Shares1,370,915,000
Market Cap$27.14 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
$19.80
-0.64 (-3.13 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OCPNY News and Ratings via Email

Sign-up to receive the latest news and ratings for OCPNY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











OLYMPUS CORP/S (OTCMKTS:OCPNY) Frequently Asked Questions

How has OLYMPUS CORP/S's stock been impacted by Coronavirus (COVID-19)?

OLYMPUS CORP/S's stock was trading at $17.6660 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OCPNY stock has increased by 12.1% and is now trading at $19.80.
View which stocks have been most impacted by COVID-19.

When is OLYMPUS CORP/S's next earnings date?

OLYMPUS CORP/S is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for OLYMPUS CORP/S.

How were OLYMPUS CORP/S's earnings last quarter?

OLYMPUS CORP/S (OTCMKTS:OCPNY) issued its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.01. The firm had revenue of $1.32 billion for the quarter, compared to analysts' expectations of $1.29 billion. OLYMPUS CORP/S had a net margin of 5.34% and a return on equity of 10.82%.
View OLYMPUS CORP/S's earnings history.

Are investors shorting OLYMPUS CORP/S?

OLYMPUS CORP/S saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 2,000 shares, a decline of 83.1% from the August 15th total of 11,800 shares. Based on an average daily trading volume, of 13,100 shares, the days-to-cover ratio is presently 0.2 days.
View OLYMPUS CORP/S's Short Interest.

Who are some of OLYMPUS CORP/S's key competitors?

Some companies that are related to OLYMPUS CORP/S include GlaxoSmithKline (GSK), Commonwealth Bank of Australia (CSLLY), Gilead Sciences (GILD), Celgene (CELG), Intuitive Surgical (ISRG), Stryker (SYK), Zoetis (ZTS), GlaxoSmithKline (GSK), Vertex Pharmaceuticals (VRTX), Becton Dickinson and (BDX), Anthem (ANTM), Regeneron Pharmaceuticals (REGN), Bayer (BAYRY), Takeda Pharmaceutical (TAK) and Boston Scientific (BSX).
View all competitors.

Who are OLYMPUS CORP/S's key executives?

OLYMPUS CORP/S's management team includes the following people:
  • Mr. Yasuo Takeuchi, Pres, CEO & Director (Age 62)
  • Mr. Yasushi Sakai, CFO & Corp. Managing Officer
  • Mr. Akihiro Taguchi, COO, Sr. Corp. Managing Exec. Officer & Director (Age 61)
  • Mr. Haruo Ogawa, CTO, Sr. Exec. Managing Officer & Director (Age 62)
  • Mr. Stefan Kaufmann, Chief Admin. Officer, Corp. Officer (Age 51)

What is OLYMPUS CORP/S's stock symbol?

OLYMPUS CORP/S trades on the OTCMKTS under the ticker symbol "OCPNY."

How do I buy shares of OLYMPUS CORP/S?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is OLYMPUS CORP/S's stock price today?

One share of OCPNY stock can currently be purchased for approximately $19.80.

How big of a company is OLYMPUS CORP/S?

OLYMPUS CORP/S has a market capitalization of $27.14 billion and generates $7.32 billion in revenue each year. The company earns $475.36 million in net income (profit) each year or $0.36 on an earnings per share basis. OLYMPUS CORP/S employs 35,174 workers across the globe.

What is OLYMPUS CORP/S's official website?

The official website for OLYMPUS CORP/S is www.olympus-global.com.

How can I contact OLYMPUS CORP/S?

OLYMPUS CORP/S's mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2111 or via email at [email protected]

This page was last updated on 9/24/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.